Protide Pharmaceuticals Inc. (PPMD/PPMD.PK) Wrap Up:

Protide Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of technologies and processes in clinical cell therapy and transfusion medicine, specifically in the areas of cancer, genetic disorders, cell engineering, and transplantation. Its products include HemaPro™, a low protein serum-free medium for clonogenic assays; Stemsol™, a sterile filtered USP Grade Dimethyl Sulfoxide (DMSO) used in a cryopreservation solution for peripheral-blood stem cells and cord blood preservations; and DMSO/Dextran, a sterile filtered USP Grade DMSO with Dextran added, which is also used in a cryopreservation solution for peripheral-blood stem cells and ...